Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2007
08/09/2007US20070185138 Imidazolopyrimidines used as fungicidal active ingredients
08/09/2007US20070185137 Therapy for disease caused by nicotinic receptors; cognition activatrors; central nervous system disorders
08/09/2007US20070185136 Sulphonamide derivatives, their preparation and their therapeutic application
08/09/2007US20070185134 Inhibitors of cyclin dependent kinases as anti-cancer agent
08/09/2007US20070185133 1-(2-{4-[5-(2-Azetidin-1-yl-ethoxy)-benzo[b]thiophen-2-y1]-5-bromo-pyrimidin-2-ylamino}-ethyl)-5,5-dimethyl-imidazolidine-2,4-dione, useful for treating diseases mediated by polo-like kinase, selected from rheumatoid arthritis and breast cancer, in a mammals; antiproliferative agents
08/09/2007US20070185132 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereo
08/09/2007US20070185131 Heterocyclic Compounds
08/09/2007US20070185130 Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
08/09/2007US20070185129 Acid addition salts of thienopyrancarboxamide derivatives
08/09/2007US20070185128 Compounds and compositions for treating obesity
08/09/2007US20070185127 2-(Arylalkoxy)-1-phenylethylamine derivatives as nk1 antagonist and serotonin reuptake inhibitors
08/09/2007US20070185126 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing Them
08/09/2007US20070185125 Pyridones useful as inhibitors of kinases
08/09/2007US20070185124 Cancer treatment with topoisomerase-ii inhibitor, a bis-dioxypiperazine and radiation
08/09/2007US20070185123 Novel compounds useful for modulating abnormal cell proliferation
08/09/2007US20070185122 Use of efletirizine for treating persistent allergic rhinitis
08/09/2007US20070185121 Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents
08/09/2007US20070185120 (4-Methyl-piperazin-1-yl)-(6H-thieno[2,3-b]pyrrol-5-yl)-methanone; (2,3-Dichloro-6H-thieno[2,3-b]pyrrol-5-yl)-(4-methyl-piperazin-1-yl)-methanone; histamine H4 receptor antagonist; treats allergic rhinitis
08/09/2007US20070185119 Therapeutic agents II
08/09/2007US20070185118 Use of methylene amide derivatives in cardiovascular disorders
08/09/2007US20070185117 Novel 14 and 15 membrered ring compounds
08/09/2007US20070185116 Bicyclic compounds
08/09/2007US20070185115 Novel ureido-and amido-pyrazolone derivatives
08/09/2007US20070185114 treating sepsis with sildenafil; enzyme inhibitor of 3',5'-cyclic nucleotide phosphodiesterases
08/09/2007US20070185113 5-chloro-1H-indole-7-carboxylic acid benzofuran-2-ylmethyl-[2-(3,4-dichloro-phenyl)-ethyl]-amide; modulates plasma lipid levels; anticholesterol agents
08/09/2007US20070185112 Piperidine/piperazine-type inhibitors of p38 kinase
08/09/2007US20070185111 N-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(3 -methyl-5-isothiazolyl)-1-phthalazinamine; anticarinogenic agents; antiproliferative agents; antiinflammatory agents; antitumor agents
08/09/2007US20070185110 pollinosis, bronchial asthma, atopic dermatitis, urticaria; endometriosis and hysteromyoma
08/09/2007US20070185109 Idene derivatives and process for the preparation thereof
08/09/2007US20070185108 Bicyclo[5.3.1]undecane-based; anticancer agents; alkylation; metathesis cyclization
08/09/2007US20070185107 Chroman compounds
08/09/2007US20070185106 Pyrrole derivatives as gonadotropin releasing hormone (gnrh) antagonists
08/09/2007US20070185105 Calcium channel blockers
08/09/2007US20070185104 Benzoxazole acetonitriles
08/09/2007US20070185103 Beta-Secretase inhibitors such as 1-cyclopentyl-N-((2S,3R)-4-((S)-6-ethyl-2,2-spirocyclobutylchroman-4-ylamino)-3-hydroxy-1-(thiophen-3-yl)butan-2-yl)-6-oxo-5-(2-oxopyrrolidin-1-yl)-1,6-dihydropyridine-3-carboxamide, useful for the treatment of Alzheimer's disease
08/09/2007US20070185102 e.g. 7,8,9,9a-Tetrahydro-6-[(3-trifluoromethyl)phenyl]-3H-naphtho[1,8-de][1,3]oxazin-2-one; congestive heart failure, hypertension, fibrosis (cardiac, kidney, and lung), primary hyperaldosteronism, hypokalemia, and liver cirrhosis
08/09/2007US20070185101 Anthelmintics, ectoparasiticides, insecticides, acaricides; for humans/animals health and in agriculture; 2-(acetyloxy)-8a-hydroxy-3,8-dimethyl-5-(1-methylethyl)-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl-6-chloro-9b-hydroxy-5-methyl-1,2,3,3a,5,9b-hexahydropyrrolo[2,3-c][2,1]benzoxazine-2-carboxylate
08/09/2007US20070185100 Poly-heterocyclic compounds and their use as metabotropic glutamate receptor antagonists
08/09/2007US20070185098 antiinflammatory agents, anticarcinogenic agents; 1-(5-tert-Butyl-3-(thiomorpholine-1,1-dioxide-4-carbonyl)thiophen-2-yl)-3-(3',4'-difluoro[1,1'-biphenyl]urea; enzyme inhibitors
08/09/2007US20070185097 7-(4-Chlorophenyl)-2-(3-methoxy-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-one trifluoroacetic acid salt; obesity; antidiabetic agents; antidepressants; anxiolytic agents; combination with antipsychotic drugs enhanced therayp for schizophrenic disorders
08/09/2007US20070185096 Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the rsv fusion protein
08/09/2007US20070185095 Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists
08/09/2007US20070185094 Novel 3-substitued-1,4-benzodiazepines
08/09/2007US20070185093 Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands
08/09/2007US20070185092 FACTOR Xa INHIBITORS
08/09/2007US20070185091 Bicyclic Heterocycles, Pharmaceutical Compositions Containing These Compounds, Their Use and Processes for Preparing Them
08/09/2007US20070185090 Muscarinic acetylchoine receptor antagonists
08/09/2007US20070185089 Benzazepine derivatives for the treatment of neurological and psychiatric disorders
08/09/2007US20070185088 M3 muscarinic acetylchoine receptor antagonists
08/09/2007US20070185087 Compounds and methods for inhibiting mitotic progression
08/09/2007US20070185086 Pharmaceutical Compositions and Methods for Effecting Dopamine Release
08/09/2007US20070185085 Noribogaine in the treatment of pain and drug addiction
08/09/2007US20070185084 Compositions of an anticonvulsant and methods of using the same for reversing weight gain
08/09/2007US20070185083 HCV NS5B Inhibitors
08/09/2007US20070185082 Treating rhinitis by topically administering an epinastine solution to the nasal mucous membrane
08/09/2007US20070185081 4-[(3-chloro-4-fluoro-phenyl)amino]-6-{[4-((1S,4S)-2-oxa-5-aza-bicyclo[2.2.1]hept-5-yl)-1-oxo-2-buten-1-yl]amino}-7-cyclopropylmethoxy-quinazoline; inhibitor of signal transduction mediated by tyrosine kinases; antitumor agent; benign prostatic hyperplasia, lungs and respiratory tract disease; bile duct
08/09/2007US20070185080 Pharmaceutical Compositions
08/09/2007US20070185079 Therapeutic agents I
08/09/2007US20070185078 e.g. 8-Methoxy-1-(2'-methoxybiphenyl-4-yl)-4H,6H-[1,2,4]triazolo[4,3-a][4,1 ]benzoxazepine; treatment of arousal disorder, orgasmic disorder, sexual pain disorder and premature ejaculation, preterm labor, appetite and feeding disorders, dysmenorrhoea, congestive heart failure
08/09/2007US20070185077 Methods of treating, preventing and inhibiting cancer metastasis and tumor formation
08/09/2007US20070185076 Antibiotic for gramnegative bacteria; prepared as an aerosolable saline solution
08/09/2007US20070185075 Pyrimidine derivatives
08/09/2007US20070185074 A kit containing 4',5'-bis(2-arsa-1,3-dithiolan-2-yl)fluorescein a nucleic acid vector encoding a fusion protein of a target and a carrier polypeptide; intermolecular labeling with high specificity and reversibility; enzyme immunoassays
08/09/2007US20070185073 viricides, parasiticide, bactericides, gene therapy and treating cisplatin refractory disease; e.g. 1,1'[[(Propane-1,3-diyl)dioxy]bis(11aS)-11-sulpho-7-methoxy-2-methylidene-1,2,3,10,11,11a-hexahydro-5H-pyrrolo[2,1-c][1,4-benzodiazepin-5-one]] sodium salt
08/09/2007US20070185072 Nitrogeneous polycyclic derivatives useful as chelators of metal ions and their applications
08/09/2007US20070185071 a compound containing cyclic tetrapeptide coupled to amide, ester, ketone groups; apoptosis and cell differentiation inducer; cancer metastasis and angiogenesis inhibitor; catalytic hydrogenation, acid treatment, fluoride anion treatment, or hydrolysis for deblocking; coupling cyclic tertrapeptide
08/09/2007US20070185070 Novel PPAR ligands that do not cause fluid retention, edema or congestive heart failure
08/09/2007US20070185069 Anti-angiogenic activity of 2-methoxyestradiol in combination with anti-cancer agents
08/09/2007US20070185068 Use of sex steroid function modulators to treat wounds and fibrotic disorders
08/09/2007US20070185067 Ciclesonide and glycopyrronium combination
08/09/2007US20070185066 Systems and methods for the delivery of corticosteroids
08/09/2007US20070185065 Combination therapy for coronary artery disease
08/09/2007US20070185064 2-Aminopurine Analogs Having HSP90-Inhibiting Activity
08/09/2007US20070185063 Seven-membered ring nucleosides
08/09/2007US20070185062 Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
08/09/2007US20070185061 (2R)-1-{2-[(3R)-pyrrolidin-3-ylamino]-acetyl}-pyrrolidine-2-boronic acid; Dipeptidyl peptidase IV (DPP-IV) inhibitors; diabetes, hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclerosis
08/09/2007US20070185060 Boronic acid thrombin inhibitors
08/09/2007US20070185059 Antiallergic agents
08/09/2007US20070185058 Heteroaryl and benzyl amide compounds
08/09/2007US20070185057 Novel Indanone Compounds
08/09/2007US20070185056 2-(2-Phenyl-2,3-dihydro-1H-inden-2-yl)-N-1,3-thiazol-2-ylacetamide; activating proteins-1 (AP-1); transactivation antagonists; side effects reduction; obesity, antidiabetic agents; non-steroidal antiinflammatory agents; immunology; osteoporosis; glaucoma; Addison's disease
08/09/2007US20070185055 Method for treating cachexia with retinoid ligands
08/09/2007US20070185054 Novel parenteral carbamazepine formulation
08/09/2007US20070185053 Single-dose needle-free administration of antithrombotic medications
08/09/2007US20070185052 Use of lipid conjugates in cystic fibrosis and applications thereof
08/09/2007US20070185051 (4S,5S,2R,3R)-5-[(2-fluorophenylthio)methyl]-2-{6-[(2-hydroxycyclopentyl)amino]-purin-9-yl }oxolane-3,4-diol; used to treat , diabetes, decreased insulin sensitivity, Polycystic Ovarian Syndrome, Stein-Leventhal syndrome, and obesity
08/09/2007US20070185045 Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers
08/09/2007US20070185041 bis-(3-deoxy-3-(4-(methylaminocarbonyl)-1H-[1,2,3]-triazol-1-yl)-beta-D-galactopyranosyl)sulfane; pharmacokinetics
08/09/2007US20070185040 Guanidinium derivatives for improved cellular transport
08/09/2007US20070185039 bis-(3-deoxy-3-benzamido- beta -D-galactopyranosyl)sulfane for example; inhibitors of galectin-3; anticancer, septic shock
08/09/2007US20070185038 Regulation of mammalian keratinous tissue using skin care actives
08/09/2007US20070185037 Sulfated oligosaccharide derivatives
08/09/2007US20070185024 Systems and methods for screening for modulators of neural differentiation
08/09/2007US20070185022 Therapeutic composiitons comprising bactericidal/permeability-increasing (BPI) protein products
08/09/2007US20070185016 Treating a Staphylococcus aureus infection by administering an antibiotic and a cyclic peptide containing a unit from a synthetic or a biosynthetic amino acid which, after cyclization, contains a lactone, thiolactone, lactam or carbonyl-containing ring
08/09/2007US20070185013 Use of chk1 inhibitors to control cell proliferation
08/09/2007US20070185010 Novel Polypeptide Hormone Phosphatonin
08/09/2007US20070185007 Inhibition of HiV integrase compounds
08/09/2007US20070184979 Novel sulfonylpyrroles
08/09/2007US20070184549 Method of inducing fenestrae
1 ... 3633 3634 3635 3636 3637 3638 3639 3640 3641 3642 3643 3644 3645 3646 3647 3648 3649 3650 3651 3652 3653 ... 7860